Association between core mutations and annual decline rate of HBVDNA and HBsAg in chronic hepatitis B patients treated with nucleoside analogue

被引：0
|
作者：
Honda, Takashi [1 ]
Ishigami, Masatoshi [1 ]
Ito, Takanori [1 ]
Ishizu, Yoji [1 ]
Kuzuya, Teiji [1 ]
Fujishiro, Mitsuhiro [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med Gastroenterol & Hepatol, Nagoya, Aichi, Japan
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30488-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-215
引用
收藏
页码：E258 / E258
页数：1
相关论文
共 50 条
  • [31] Mutations in Core Gene Region of Hepatitis B Virus in Patients with Chronic Hepatitis B
    Ciftci, Sevgi
    Keskin, Fahriye
    Abaci, Neslihan
    Akyuz, Filiz
    Cakiris, Aris
    Badur, Selim
    Kaymakoglu, Sabahattin
    Ustek, Duran
    CLINICAL LABORATORY, 2018, 64 (03) : 303 - 310
  • [32] Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B
    Kurosaki, M
    Enomoto, N
    Asahina, Y
    Sakuma, I
    Ikeda, T
    Tozuka, S
    Izumi, N
    Marumo, F
    Sato, C
    JOURNAL OF MEDICAL VIROLOGY, 1996, 49 (02) : 115 - 123
  • [33] Incidence of hepatocellular carcinoma in chronic hepatitis B patients responders to nucleoside analogue treatment
    Singeap, A-M
    Trifan, A.
    Girleanu, I.
    Cojocariu, C.
    Sfarti, C.
    Stanciu, C.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 49 - 50
  • [34] Predictors of Serum HBsAg Decline in Chronic Hepatitis B Patients Undergoing Entecavir Therapy
    Lai, Hsueh-Chou
    Peng, Cheng-Yuan
    Su, Wen-Pang
    Lin, Chia-Hsin
    Chuang, Po-Heng
    Kao, Jon-Ta
    Chen, Sheng-Hung
    HEPATOLOGY, 2013, 58 : 662A - 662A
  • [35] Predictors of Serum HBsAg Decline in Chronic Hepatitis B Patients Undergoing Entecavir Therapy
    Lai, Hsueh-Chou
    Peng, Cheng-Yuan
    Su, Wen-Pang
    Lin, Chia-Hsin
    Chuang, Po-Heng
    Kao, Jung-Ta
    Chen, Sheng-Hung
    HEPATOLOGY, 2012, 56 : 396A - 396A
  • [36] QUANTITATIVE HBSAG LEVELS IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH LAMIVUDINE AND ADEFOVIR
    Villeneuve, Jean-Pierre
    Montcalm, Lorraine
    Trudel, Louise
    Castel, Helene
    Fournier, Claire
    Willems, Bernard E.
    HEPATOLOGY, 2009, 50 (04) : 512A - 512A
  • [37] PRESENCE OF ONLY WILDTYPE VIRUS IS THE STRONGEST DETERMINANT OF HBVDNA UNDETECTABILITY AND HBSAG CLEARANCE IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON
    Sonneveld, M. J.
    Rijckborst, V.
    Zeuzem, S.
    Heathcote, E. J.
    Simon, K.
    Senturk, H.
    Pas, S. D.
    Hansen, B. E.
    Janssen, H. L.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S24 - S24
  • [38] Association between Quantitative Serum HBsAg Level and Therapeutic Response to Entecavir in Patients with Chronic Hepatitis B
    Peng, Cheng-Yuan
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Lin, Chia-Hsin
    Chuang, Po-Heng
    Kao, Jung-Ta
    Chen, Sheng-Hung
    HEPATOLOGY, 2012, 56 : 367A - 368A
  • [39] Editorial: can hepatitis B core-related antigen be the new biomarker for hepatocellular carcinoma in nucleoside analogue-treated chronic hepatitis B? Author's reply
    Hosaka, Tetsuya
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (07) : 955 - 955
  • [40] Association between Hepatitis B Virus X Gene Mutations and Clinical Status in Patients with Chronic Hepatitis B Infection
    Cho, Eun Young
    Choi, Chang Soo
    Cho, Ji-Hyun
    Kim, Haak Cheoul
    GUT AND LIVER, 2011, 5 (01) : 70 - 76
12345